Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights GlobeNewswire November 13, 2025 – Pre-NDA meeting with FDA to discuss brilaroxazine's path to approval for schizophrenia planned in Q4 2025 – – Potential NDA submission for schizophrenia indication targeted for Q2 2026 – – European patent granted covering use of brilaroxazine for the […]
Robinhood Markets, Inc. Reports October 2025 Operating Data GlobeNewswire November 13, 2025 MENLO PARK, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for October 2025. Funded Customers at the end of October were 27.1 million (up approximately 210 thousand from September 2025, up approximately
eGain to Participate in the Roth Technology Conference on November 19, 2025 GlobeNewswire November 13, 2025 SUNNYVALE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), an AI CX automation platform provider, today announced that CFO Eric Smit and VP of Finance Gautam Garg will host meetings with institutional investors at the 14th Annual
nCino Announces Timing of its Third Quarter Fiscal Year 2026 Financial Results Conference Call GlobeNewswire November 13, 2025 WILMINGTON, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, will report financial results for its third quarter ended October 31, 2025, after the market close on
Birchtech Reports Third Quarter 2025 Financial Results GlobeNewswire November 13, 2025 Third Quarter 2025 Revenues Increased 41% to $7.4 Million, Driving Net Income of $0.8 Million CORSICANA, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) (“Birchtech” or the “Company”), a leader in specialty activated carbon technologies for sustainable air and
Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates GlobeNewswire November 13, 2025 Aardvark has aligned with the FDA to reduce the minimum age of eligibility from 13 to 10 years old for pediatric patients in HERO, the Phase 3 trial of ARD-101 for the treatment of hyperphagia associated with
Astera Labs Announces Fourth Quarter 2025 Financial Conference Participation GlobeNewswire November 13, 2025 SAN JOSE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — Astera Labs (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it will participate in the following upcoming financial conferences during the fourth quarter 2025: 2025 RBC Capital
Maris-Tech Enters Quantum Navigation Field with Strategic Agreement to Develop Quantum-Based Gyroscope to Replace GPS Navigation GlobeNewswire November 13, 2025 Maris-Tech will Obtain Controlling Interest in the New Company Rehovot, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in video and artificial intelligence (“AI”)
In a rapidly shifting global landscape, we are building One Canadian Economy turbo-charged by major nation-building projects that unleash our natural resources, diversify our products and markets and create hundreds of thousands of high-paying careers for our workers, all while protecting the environment and upholding the rights of Indigenous Peoples. Budget 2025 is the government's
(NYSE:LRN), SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Stride, Inc. (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”), have until January 12, 2026 to seek appointment as lead plaintiff of the